Literature DB >> 31068307

[Long non-coding RNA XIST modulates cisplatin resistance by altering PDCD4 and Fas-Lexpressions in human nasopharyngeal carcinoma HNE1 cells in vitro].

Hao Wang1, Wei Li1, Guolin Tan1.   

Abstract

OBJECTIVE: To explore the role of long non-coding RNA (lncRNA) X inactive specific transcript (XIST) in modulating cisplatin (DDP) resistance of human nasopharyngeal carcinoma cells and investigate the possible mechanism.
METHODS: Realtime PCR was performed to detect the expression of XIST in cisplatin-resistant human nasopharyngeal carcinoma cell line HNE1/DDP. The effects of up-regulation and down-regulation of XIST on DDP resistance, proliferation and apoptosis of HNE1/ DDP cells were assessed using MTT assay, EdU assay and flow cytometry. Western blotting was used to detect the changes in the expressions of programmed cell death 4 (PDCD4) and Fas ligand (Fas-L) proteins in the cells in response to up-regulation or down-regulation of XIST.
RESULTS: The expression of XIST was significantly up-regulated in HNE1/DDP cells in comparison with HNE1 cells (0.57±0.06 vs 0.1±0.02, P < 0.05). Down-regulation of XIST significantly decreased while up-regulation of XIST obviously increased DDP resistance of HNE1/DDP cells (P < 0.05). Down-regulation of XIST significantly reduced the proliferation (6.17 ± 1.93 vs 16.59 ± 4.86, P < 0.05) and enhanced apoptosis [(18.04 ± 4.72)% vs (4.22 ± 1.65)%, P < 0.05], while upregulating XIST enhanced the proliferation (25.40±7.21 vs 13.16±3.95, P < 0.05) and inhibited apoptosis [(2.82±0.88)% vs (6.46± 1.75)%, P < 0.05] in HNE1/DDP cells. Down-regulation of XIST significantly increased the protein expressions of PDCD4 and Fas-L (P < 0.05) in HNE1/DDP cells, and up-regulation of XIST resulted in reverse changes in PDCD4 and Fas-L expressions (P < 0.05).
CONCLUSIONS: XIST is up-regulated in HNE1/DDP cells, and down-regulation and up-regulation of XIST expression reduce and increase DDP resistance of the cells, respectively, possibly as a result of changes in the expressions of PDCD4 and Fas-L.

Entities:  

Keywords:  Fas; X inactive specific transcript; cisplatin; drug resistance; nasopharyngeal carcinoma; programmed cell death 4

Mesh:

Substances:

Year:  2019        PMID: 31068307      PMCID: PMC6765679          DOI: 10.12122/j.issn.1673-4254.2019.03.15

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  31 in total

1.  Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1.

Authors:  Jia Zhu; Rui Zhang; Dongxiang Yang; Jibin Li; Xiaofei Yan; Keer Jin; Wenya Li; Xin Liu; Jianfeng Zhao; Wen Shang; Tao Yu
Journal:  Cell Physiol Biochem       Date:  2018-11-15

Review 2.  Nasopharyngeal carcinoma.

Authors:  Sophia C Kamran; Nadeem Riaz; Nancy Lee
Journal:  Surg Oncol Clin N Am       Date:  2015-04-11       Impact factor: 3.495

3.  Expanding the functional role of long noncoding RNAs.

Authors:  Per Johnsson; Kevin V Morris
Journal:  Cell Res       Date:  2014-08-08       Impact factor: 25.617

Review 4.  Functions and Roles of Long-Non-Coding RNAs in Human Nasopharyngeal Carcinoma.

Authors:  JingJing Wu; Swei Sunny Hann
Journal:  Cell Physiol Biochem       Date:  2018-02-09

5.  LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i/BAG-1 axis.

Authors:  Jing Sun; Li-Ming Pan; Li-Bo Chen; Yue Wang
Journal:  Cell Cycle       Date:  2017-09-29       Impact factor: 4.534

6.  Global trends in incidence and mortality of nasopharyngeal carcinoma.

Authors:  Ling-Ling Tang; Wan-Qing Chen; Wen-Qiong Xue; Yong-Qiao He; Rong-Shou Zheng; Yi-Xin Zeng; Wei-Hua Jia
Journal:  Cancer Lett       Date:  2016-01-29       Impact factor: 8.679

7.  LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway.

Authors:  Peng Du; Haiting Zhao; Renjun Peng; Qing Liu; Jian Yuan; Gang Peng; Yiwei Liao
Journal:  Biosci Rep       Date:  2017-09-07       Impact factor: 3.840

8.  Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy.

Authors:  Wei Sun; Yukun Zu; Xiangning Fu; Yu Deng
Journal:  Oncol Rep       Date:  2017-10-24       Impact factor: 3.906

9.  CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.

Authors:  Yang Li; Li-Ru He; Ying Gao; Ning-Ning Zhou; Yurong Liu; Xin-Ke Zhou; Ji-Fang Liu; Xin-Yuan Guan; Ning-Fang Ma; Dan Xie
Journal:  Cell Death Dis       Date:  2019-02-04       Impact factor: 8.469

Review 10.  Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance.

Authors:  Paola Giussani; Cristina Tringali; Laura Riboni; Paola Viani; Bruno Venerando
Journal:  Int J Mol Sci       Date:  2014-03-12       Impact factor: 5.923

View more
  1 in total

Review 1.  Biological Function of Long Non-coding RNA (LncRNA) Xist.

Authors:  Wenlun Wang; Lu Min; Xinyuan Qiu; Xiaomin Wu; Chuanyang Liu; Jiaxin Ma; Dongyi Zhang; Lingyun Zhu
Journal:  Front Cell Dev Biol       Date:  2021-06-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.